SHELL ASSET MANAGEMENT CO - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$426
+4.2%
11,156
-1.7%
0.02%
+12.5%
Q2 2023$409
+19.2%
11,350
+26.3%
0.02%
+14.3%
Q1 2023$343
-33.1%
8,983
-0.3%
0.01%
-36.4%
Q4 2022$513
-99.9%
9,014
-16.7%
0.02%
+29.4%
Q3 2022$428,000
-15.1%
10,822
-5.6%
0.02%
+13.3%
Q2 2022$504,000
+57.0%
11,460
+42.6%
0.02%
+87.5%
Q1 2022$321,000
-13.5%
8,038
-12.9%
0.01%0.0%
Q4 2021$371,000
-0.8%
9,226
+0.5%
0.01%0.0%
Q3 2021$374,000
-14.0%
9,182
-4.1%
0.01%0.0%
Q2 2021$435,000
+74.0%
9,572
+59.4%
0.01%
+60.0%
Q1 2021$250,000
-55.4%
6,006
-54.3%
0.01%
-58.3%
Q4 2020$561,000
+62.6%
13,1460.0%0.01%
+50.0%
Q3 2020$345,000
-2.0%
13,1460.0%0.01%
-11.1%
Q2 2020$352,000
+47.3%
13,146
-1.1%
0.01%
+28.6%
Q1 2020$239,0000.0%13,291
-1.5%
0.01%
+40.0%
Q4 2019$239,000
+11.7%
13,493
-2.1%
0.01%0.0%
Q3 2019$214,000
-10.5%
13,788
-0.8%
0.01%0.0%
Q2 2019$239,000
+4.4%
13,906
-2.2%
0.01%0.0%
Q1 2019$229,00014,2240.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders